This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
27 - 29 May, 2026
Congress CenterBasel Switzerland

Dr. Paul Sauter, PhD
Senior Director ADC Tech & Chemistry at Veraxa Biotech
Speaker

Profile

Paul Sauter, PhD, Senior Director ADC Tech & Chemistry, has a strong background in organic chemistry with a focus on synthesis. He holds a Ph.D. in natural sciences from the Karlsruhe Institute of Technology and pursued post-doctoral studies at the European Molecular Biology Laboratory (EMBL), working on bioorthogonal click chemistry. He has been building VERAXA’s current ADC technology and ADC chemistry department since inception, starting at ARAXA Biosciences as Head of Chemistry and continuing the development and growth after merging to VERAXA Biotech as Director of Chemistry & Bioconjugation. His current main interest is the establishment of VERAXA’s dual targeting BiTAC ADC platform.

Agenda Sessions

  • Breakthrough Innovations in ADCs through Dual Targeting: From AND-gated bispecific ADCs to the Conditional Active BiTAC ADC Platform

    11:00